AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic June 6, 2023
Lassen Therapeutics Presents Phase I Data on LASN01, an IL-11 Receptor-Blocking Antibody for Treatment of Pulmonary Fibrosis May 25, 2023
TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors May 25, 2023
Colorescience Introduces First of its Kind, Patent-Pending No-Show Mineral Sunscreen SPF 50 May 24, 2023
